Cargando…
Drugs acting on the renin–angiotensin system and SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the ongoing global Coronavirus 2019 (COVID-19) pandemic, resulting in thousands of deaths worldwide and representing a health challenge with few precedents in human history. Angiotensin-converting enzyme 2 (ACE-2) facili...
Autores principales: | Vitiello, Antonio, Pelliccia, Chiara, Ferrara, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825840/ https://www.ncbi.nlm.nih.gov/pubmed/33486116 http://dx.doi.org/10.1016/j.drudis.2021.01.010 |
Ejemplares similares
-
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021) -
Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021) -
Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022) -
The fight against COVID-19: Striking a balance in the renin–angiotensin system
por: Dean, Alexis Q., et al.
Publicado: (2021) -
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021)